Microplastics Can Disrupt the Lung’s Immune Housekeeping System

A recent study highlighted an unexpected response to inhaled microplastics: the particles did not simply get swallowed by lung immune cells and disappear. In an investigation presented at the American Thoracic Society’s 2025 International Conference, researchers found that pulmonary macrophages retained polystyrene particles and became less effective at engulfing bacteria.

That distinction matters. The popular image of microplastics is a particle that enters the body and causes irritation. The newer research raises a more specific question: could some particles interfere with the ordinary “housekeeping” work performed by immune cells? The answer is not settled, but the mechanism deserves attention because it offers a clearer way to think about exposure, persistence, and risk without jumping from a preclinical result to a diagnosis.

What the University of Pittsburgh study actually found

The study, led by researchers at the University of Pittsburgh and presented as “Inhaled Microplastics Inhibit Tissue Maintenance Functions of Pulmonary Macrophages” at ATS 2025, used cultured macrophages and mice exposed to inhaled polystyrene microplastics. Macrophages are white blood cells that help maintain tissue health. In the lungs, they can engulf bacteria and cellular debris, helping the respiratory system balance defense with repair.

In the abstract, macrophage phagocytosis – the process of surrounding and absorbing a target – was reduced within 24 hours after exposure to particles of different sizes. The researchers also reported that the cells struggled to break down the plastic in laboratory experiments. The American Thoracic Society research release provides additional context from the presenting team.

The mouse data added a second finding. Microplastics were detected in the liver, spleen, and colon after inhalation, with trace amounts reported in the brain and kidneys for up to one week. This does not establish what those particles did in each organ, how long they would remain in a human body, or whether the exposure level matches ordinary human exposure. It does show why “the lungs” may be only the first chapter of an inhalation story.

The net-new insight: an immune cell can be present but less capable

Many discussions of microplastics focus on whether particles provoke inflammation. That is an important line of research, but the macrophage findings point to another possibility: an immune cell may still be there while performing its normal jobs less efficiently.

Think of a lung macrophage as a maintenance worker rather than a one-time alarm bell. It surveys the air–tissue interface, clears debris, responds to microbes, and helps prevent leftover cellular material from accumulating. If an indigestible particle remains inside the cell, the issue may be less about an immediate inflammatory burst and more about the cell’s available capacity.

The group’s subsequent bioRxiv preprint proposes one explanation: micro- and nanoplastics may impair macrophage mitochondrial function, which could affect the energy-intensive process of phagocytosis. The preprint also reports altered antigen presentation in experimental models. These results are potentially important, but they are not yet peer-reviewed clinical evidence, and the models cannot tell us the magnitude of risk for an individual person. The original ATS abstract is available through the American Journal of Respiratory and Critical Care Medicine.

This “capacity” framing adds useful context to the exposure conversation. It suggests that particle size, polymer type, dose, route of exposure, retention time, and the surrounding biological environment may all matter. “Microplastics” is not one uniform substance, and a laboratory polystyrene particle should not be assumed to behave like every particle encountered in food, water, dust, or air.

Why inhalation research still matters if your main concern is food and water

Sifts is focused on ingested exposure, but the lung study is relevant because people encounter plastic particles through more than one route. Airborne fibers and dust can be inhaled, while particles in food and water enter the digestive tract. These routes lead to different first-contact tissues and may involve different particle sizes and clearance processes.

That is also why a respiratory finding should not be used to claim that a gut supplement protects the lungs. The study did not test Sifts, chitosan, apple pectin, baobab, slippery elm, or magnesium glycinate. It did not show that binding particles in the digestive tract changes pulmonary macrophage function. The scientifically responsible connection is narrower: reducing avoidable exposure by multiple routes is sensible, while research into gastrointestinal handling addresses a separate part of the overall exposure picture.

For a practical overview of exposure reduction, see 8 Practical Ways to Reduce Microplastic Exposure. The goal is not perfect avoidance, which is unrealistic. It is to reduce high-contact, high-heat, and high-friction situations where simple substitutions are available.

What this means for digestion and elimination

Particles that are swallowed face a different environment from particles that reach the lungs. The digestive tract contains fluid, enzymes, bile, mucus, microbes, and dietary fibers. Some particles may pass through, some may interact with food or mucus, and the smallest particles may behave differently from larger fragments. Researchers are still working to determine how these variables influence retention and excretion in people.

This is where mechanism-based nutrition research may eventually add a useful, limited piece of the picture. Chitosan is a positively charged polysaccharide that can interact electrostatically with certain negatively charged particles under laboratory conditions. Fibers such as pectin may contribute to a viscous matrix in the digestive tract. These observations support further testing; they do not establish that a finished supplement binds every type of microplastic or changes health outcomes.

Research on microplastics and the gut also underscores an important boundary: a plausible mechanism is not the same as a demonstrated clinical benefit. For Sifts, the relevant research question is whether its ingredients interact with ingested particles under realistic digestive conditions and whether that interaction is associated with normal fecal excretion. Those questions require ingredient-specific laboratory work and, ultimately, carefully designed human studies.

A practical, evidence-aware protocol

There is no proven “lung detox” protocol for microplastics, and a supplement should not be positioned as a shield against inhaled pollution. A more grounded approach is to separate what has a reasonable evidence basis from what remains experimental.

Sifts is formulated with chitosan and fibers that are being studied for how they interact with particles during digestion. If you choose to explore Sifts, the appropriate expectation is ingredient-level gastrointestinal support – not a medical intervention and not a substitute for reducing exposure at its source.*

What researchers need to answer next

The most important next step is moving from controlled exposure models to better human evidence. Researchers need to determine whether microplastics can be measured consistently in human lung tissue, whether macrophage function is altered at ordinary exposure levels, and which particle characteristics are most relevant.

They also need standardized methods. As Stanford Medicine has explained in its overview of the field, scientists still lack consistent techniques for identifying and quantifying microplastics, especially nanoplastics. Without reliable measurement, it is difficult to compare studies or connect an exposure level to a biological response.

For the digestive route, useful endpoints might include particle recovery in stool, changes in particle size or aggregation during simulated digestion, and safety measures such as nutrient interactions. A human study would need to distinguish an ingredient effect from changes caused by diet, transit time, background exposure, and measurement variability.

The new macrophage findings therefore deserve attention without panic. They add a plausible mechanism to a growing research field: persistent particles may alter the function of the cells that encounter them. But the work is not a diagnosis, not proof of causation in people, and not evidence that one product can solve a multi-route exposure problem. The most credible response remains layered – reduce avoidable contact, support ordinary health habits, and demand better human data.

Frequently asked questions